Theresa Hunter Gibble (Theresa Hunter, Theresa H Gibble, Theresa M Hunter)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 28

Top Topics

Cross Sectional

Disease Activity

Ulcerative Colitis

Radical Prostatectomy

Top Venues

Current medical research and opinion

Crohn's & colitis 360

Inflammatory bowel diseases

Journal of patient-reported outcomes

This page only lists publications with an associated author ORCID identifier.

Publications

Theresa Hunter Gibble, Mingyang Shan, Xian Zhou, April N Naegeli, Suchita Dubey, James D Lewis
Association of fatigue with disease activity and clinical manifestations in patients with crohn's disease and ulcerative colitis: an observational cross-sectional study in the United States. Current medical research and opinion (2024)
Vipul Jairath, Theresa Hunter Gibble, Alison Potts Bleakman, Kaitlin Chatterton, Paolo Medrano, Megan McLafferty, Brittany Klooster, Sonal Saxena, Richard Moses
Patient Perspectives of Bowel Urgency and Bowel Urgency-Related Accidents in Ulcerative Colitis and Crohn's Disease. Inflammatory bowel diseases (2024)
Miguel Regueiro, Monika Fischer, Peter Bossuyt, Kim McGinnis, Marijana Protic, Theresa Hunter Gibble, Tommaso Panni, Lai Shan Chan, Toshifumi Hibi, David T Rubin
Mirikizumab Sustained Impact on Fatigue in Patients with Moderately to Severely Active Crohn's Disease in the Phase 2 AMAG Study. Inflammatory bowel diseases (2024)
Theresa Hunter Gibble, Mingyang Shan, Xian Zhou, April N Naegeli, Suchita Dubey, James D Lewis
Association of fatigue with disease activity and clinical manifestations in patients with Crohn's disease and ulcerative colitis: an observational cross-sectional study in the United States. Current medical research and opinion 40 (9) (2024)
Theresa Hunter Gibble, Mingyang Shan, Xian Zhou, April N Naegeli, Suchita Dubey, James D Lewis
Association of fatigue with disease activity and clinical manifestations in patients with Crohn's disease and ulcerative colitis: an observational cross-sectional study in the United States. Current medical research and opinion 40 (9) (2024)
Geert R A M D'Haens, Peter D R Higgins, Laurent Peyrin-Biroulet, Bruce E Sands, Scott Lee, Richard E Moses, Isabel Redondo, Rodrigo Escobar, Theresa Hunter Gibble, Anthony Keohane, Nathan Morris, Xin Zhang, Vipin Arora, Taku Kobayashi
Extended Induction and Prognostic Indicators of Response in Patients Treated with Mirikizumab with Moderately to Severely Active Ulcerative Colitis in the LUCENT Trials. Inflammatory bowel diseases (2024)
Theresa Hunter Gibble, Mingyang Shan, Xian Zhou, April N Naegeli, Suchita Dubey, James D Lewis
Association of fatigue with disease activity and clinical manifestations in patients with Crohn's disease and ulcerative colitis: an observational cross-sectional study in the United States. Current medical research and opinion (2024)
Millie D Long, Stefan Schreiber, Toshifumi Hibi, Theresa Hunter Gibble, Deborah A Fisher, Gina Park, Richard E Moses, Peter D R Higgins, James O Lindsay, Scott D Lee, Rodrigo Escobar, Vipul Jairath
Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) Studies. Crohn's & colitis 360 6 (1) (2024)
Theresa Hunter Gibble, Mingyang Shan, Xian Zhou, April N Naegeli, Suchita Dubey, James D Lewis
Association of fatigue with disease activity and clinical manifestations in patients with Crohn's disease and ulcerative colitis: an observational cross-sectional study in the United States. Current medical research and opinion (2024)
Gisela Felten, Isabel Redondo, Petra Streit, Marijana Protic, Susanne Hartz, Gamze Gurses, Hannah Knight, Sophie Barlow, Niamh Harvey, Theresa Hunter Gibble
Burden of Bowel Urgency in Patients With Ulcerative Colitis and Crohn's Disease: A Real-World Global Study. Crohn's & colitis 360 6 (3) (2024)
Silvio Danese, Axel Dignass, Katsuyoshi Matsuoka, Marc Ferrante, Millie Long, Isabel Redondo, Richard Moses, Sebastian Maier, Theresa Hunter Gibble, Nathan Morris, Catherine Milch, Maria T Abreu
Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Program. Journal of Crohn's & colitis (2024)
Millie D Long, Stefan Schreiber, Toshifumi Hibi, Theresa Hunter Gibble, Deborah A Fisher, Gina Park, Richard E Moses, Peter D R Higgins, James O Lindsay, Scott D Lee, Rodrigo Escobar, Vipul Jairath
Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) Studies. Crohn's & colitis 360 6 (1) (2024)
Marla C Dubinsky, Laure Delbecque, Theresa Hunter Gibble, Gale Harding, Larissa Stassek, Richard E Moses, James D Lewis
Validation of the bowel urgency numeric rating scale in patients with Crohn's disease: results from a mixed methods study. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2023)
Miguel Regueiro, Laure Delbecque, Theresa Hunter Gibble, Larissa Stassek, Gale Harding, James Lewis
Experience and measurement of fatigue in adults with Crohn's disease: results from qualitative interviews and a longitudinal 2-week daily diary pilot study. Journal of patient-reported outcomes 7 (1) (2023)
Javier P Gisbert, Petra Streit, Isabel Redondo, Susanne Hartz, Hannah Knight, Emily Quinones, Niamh Harvey, Vanda Palace, Theresa Hunter Gibble
Clinical profiles and outcomes in patients with ulcerative colitis receiving standard and higher-than-standard doses of vedolizumab: findings from a real-world study in Europe. Current medical research and opinion (2023)
Chaochen Wang, Tomoko Ishizuka, Masaru Tanaka, Koji Matsuo, Hannah Knight, Niamh Harvey, Liane Gillespie-Akar, Theresa Hunter Gibble
Bowel Urgency in Patients with Ulcerative Colitis and Crohn's Disease: A Cross-Sectional Real-World Survey in Japan. Advances in therapy (2023)
Christina Y Ha, April N Naegeli, Rina Lukanova, Mingyang Shan, Rosie Wild, Fritha Hennessy, Uma Jyothi Kommoju, Alison Potts Bleakman, Theresa Hunter Gibble
Rectal Urgency Among Patients With Ulcerative Colitis or Crohn's Disease: Analyses from a Global Survey. Crohn's & colitis 360 5 (4) (2023)
Philip J Mease, Taylor Blachley, William N Malatestinic, Leslie R Harrold, Blessing Dube, Jeffrey R Lisse, Rebecca J Bolce, Theresa Hunter Gibble
Effectiveness of bDMARDs in ankylosing spondylitis patients by biologic use: experience from the CorEvitas PsA/SpA Registry. Current medical research and opinion (2023)
Axel Dignass, Isabel Redondo, Petra Streit, Susanne Hartz, Gamze Gurses, Hannah Knight, Sophie Barlow, Niamh Harvey, Theresa Hunter Gibble
Clinical profiles and outcomes in patients with inflammatory bowel disease receiving standard and escalated doses of targeted therapies: findings from a global real-world study. Current medical research and opinion (2023)
Bruce E Sands, Brian G Feagan, Theresa Hunter Gibble, Kristina A Traxler, Nathan Morris, William J Eastman, Stefan Schreiber, Vipul Jairath, Millie D Long, Alessandro Armuzzi
Mirikizumab Improves Quality of Life in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From the Phase 3 LUCENT-1 Induction and LUCENT-2 Maintenance Studies. Crohn's & colitis 360 5 (4) (2023)
Fabian Proft, Susanne Lüders, Theresa Hunter Gibble, Gustavo Luna, Valeria Rios Rodriguez, Mikhail Protopopov, Katharina Meier, Georgios Kokolakis, Kamran Ghoreschi, Denis Poddubnyy
Early identification of axial psoriatic arthritis among patients with psoriasis: a prospective multicentre study. Annals of the rheumatic diseases (2022)
Theresa Hunter Gibble, Wendy J Komocsar, Chunyan Liu, Richard B Colletti, Steven J Steiner, Jennifer L Dotson, Keith Benkov, Nanhua Zhang, Wallace Crandall
Clinical Outcome Assessments in Pediatric Patients With Ulcerative Colitis and Crohn's Disease Receiving Biologics: A Retrospective Cohort Study. Crohn's & colitis 360 4 (2) (2022)
Marla C Dubinsky, Mingyang Shan, Laure Delbecque, Trevor Lissoos, Theresa Hunter Gibble, Gale Harding, Larissa Stassek, David Andrae, James D Lewis
Psychometric evaluation of the Urgency NRS as a new patient-reported outcome measure for patients with ulcerative colitis. Journal of patient-reported outcomes 6 (1) (2022)
Miguel Regueiro, Theresa Hunter Gibble, Rina Lukanova, Mingyang Shan, Rosie Wild, Hannah Knight, Priyanka Bannikoppa, April N Naegeli
Burden of Fatigue Among Patients with Ulcerative Colitis and Crohn's Disease: Results from a Global Survey of Patients and Gastroenterologists. Advances in therapy (2022)
Theresa Hunter Gibble, Wendy J Komocsar, Chunyan Liu, Richard B Colletti, Steven J Steiner, Jennifer L Dotson, Keith Benkov, Nanhua Zhang, Wallace Crandall
Clinical Outcome Assessments in Pediatric Patients With Ulcerative Colitis and Crohn's Disease Receiving Biologics: A Retrospective Cohort Study. Crohn's & colitis 360 4 (2) (2022)
Theresa Hunter Gibble, Michael Grabner, Julie Birt, Keith Isenberg, Mingyang Shan, Chia-Chen Teng, Jianmin Wu, Kirstin Griffing, Jeffrey Lisse, Jeffrey R Curtis
Identifying inadequate response among patients with ankylosing spondylitis and psoriatic arthritis prescribed advanced therapy in a real-world, commercially insured adult population in the USA. Clinical rheumatology 41 (9) (2022)
William Benjamin Nowell, Kelly Gavigan, Theresa Hunter Gibble, William N Malatestinic, Rebecca J Bolce, Jeffrey R Lisse, Carol Himelein, Jeffrey R Curtis, Jessica A Walsh
Treatment Satisfaction and Decision-making from the Patient Perspective in Axial Spondyloarthritis: Real-World Data from a Descriptive Cross-sectional Survey Study from the ArthritisPower Registry. ACR open rheumatology (2021)
Jessica A Walsh, Marina N Magrey, Xenofon Baraliakos, Kentaro Inui, Meng-Yu Weng, Ennio Lubrano, Désirée van der Heijde, Annelies Boonen, Lianne S Gensler, Vibeke Strand, Jürgen Braun, Theresa Hunter Gibble, Xiaoqi Li, Baojin Zhu, Luis León, David Marcelino Sandoval Calderon, Uta Kiltz
Ixekizumab Improves Functioning and Health in the Treatment of Active Non-Radiographic Axial Spondyloarthritis: 52-Week Results, COAST-X Trial. Arthritis care & research (2020)